Related references
Note: Only part of the references are listed.The Effects of Vitamin D on Skeletal Muscle Strength, Muscle Mass, and Muscle Power: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Charlotte Beaudart et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Long-term effects of a ketogenic diet on body composition and bone mineralization in GLUT-1 deficiency syndrome: A case series
Simona Bertoli et al.
NUTRITION (2014)
The impact of the use of antiepileptic drugs on the growth of children
Herng-Sheng Lee et al.
BMC PEDIATRICS (2013)
The association between BsmI polymorphism and bone mineral density in young patients with epilepsy who are taking phenytoin
Kanitpong Phabphal et al.
EPILEPSIA (2013)
Effects of levetiracetam as a monotherapy on bone mineral density and biochemical markers of bone metabolism in patients with epilepsy
Dae Lim Koo et al.
EPILEPSY RESEARCH (2013)
Age-related inducibility of carboxylesterases by the antiepileptic agent phenobarbital and implications in drug metabolism and lipid accumulation
Da Xiao et al.
BIOCHEMICAL PHARMACOLOGY (2012)
Bisphosphonates Use in Children
Judith F. Sebestyen et al.
CLINICAL PEDIATRICS (2012)
Bone mineral density in a population of children and adolescents with cerebral palsy and mental retardation with or without epilepsy
Giangennaro Coppola et al.
EPILEPSIA (2012)
Bone turnover markers: use in osteoporosis
Kim Naylor et al.
NATURE REVIEWS RHEUMATOLOGY (2012)
Treatment of Epilepsy to Optimize Bone Health
Alison M. Pack
CURRENT TREATMENT OPTIONS IN NEUROLOGY (2011)
BsmI vitamin D receptor's polymorphism and bone mineral density in men and premenopausal women on long-term antiepileptic therapy
I. Lambrinoudaki et al.
EUROPEAN JOURNAL OF NEUROLOGY (2011)
DXA Measurements in Rett Syndrome Reveal Small Bones With Low Bone Mass
Gitte Roende et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2011)
The effects of antiepileptic drugs on the relationships between leptin levels and bone turnover in prepubertal children with epilepsy
Ayse Aksoy et al.
JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2011)
Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis
Mark J. Bolland et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
INITIAL AND MAINTENANCE DOSES OF VITAMIN D2 IN THE TREATMENT OF ANTICONVULSANT OSTEOMALACIA
C. Christiansen et al.
ACTA NEUROLOGICA SCANDINAVICA (2010)
Bone and calcium metabolism and antiepileptic drugs
Alberto Verrotti et al.
CLINICAL NEUROLOGY AND NEUROSURGERY (2010)
A 12-month longitudinal study of calcium metabolism and bone turnover during valproate monotherapy
A. Verrotti et al.
EUROPEAN JOURNAL OF NEUROLOGY (2010)
Fractures in epilepsy children
Anna Gniatkowska-Nowakowska
SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2010)
Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis
Steven R. Cummings et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The tolerability and biochemical effects of high-dose bolus vitamin D2 and D3 supplementation in patients with vitamin D insufficiency
P. Leventis et al.
SCANDINAVIAN JOURNAL OF RHEUMATOLOGY (2009)
Vitamin D and vitamin D analogues for preventing fractures associated with involutional and post-menopausal osteoporosis
Alison Avenell et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2009)
Progressive bone mineral content loss in children with intractable epilepsy treated with the ketogenic diet
A. G. Christina Bergqvist et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2008)
Predictors of bone density in ambulatory patients on antiepileptic drugs
Ghada El-Hajj Fuleihan et al.
BONE (2008)
Gender differences in bone mineral density in epilepsy
Raj D. Sheth et al.
EPILEPSIA (2008)
Bone in idiopathic and symptomatic epilepsy
Raj D. Sheth et al.
EPILEPSY RESEARCH (2008)
Evaluation of Bone Turnover in Epileptic Children Using Oxcarbazepine
Ali Cansu et al.
PEDIATRIC NEUROLOGY (2008)
Progressive bone deficit in epilepsy
Raj D. Sheth et al.
NEUROLOGY (2008)
Adverse effects of antiepileptic drugs on bone mineral density in children
Tina Gissel et al.
EXPERT OPINION ON DRUG SAFETY (2007)
Bone mineral density in Angelman syndrome
[Anonymous]
PEDIATRIC NEUROLOGY (2007)
Two randomized vitamin D trials in ambulatory patients on anticonvulsants - Impact on bone
M. A. Mikati et al.
NEUROLOGY (2006)
Vitamin D levels and bone turnover in epilepsy patients taking carbamazepine or oxcarbazepine
S Mintzer et al.
EPILEPSIA (2006)
Application of the 1994 WHO classification to populations other than postmenopausal Caucasian women: The 2005 ISCD official positions
William D. Leslie et al.
JOURNAL OF CLINICAL DENSITOMETRY (2006)
Adverse effects of antiepileptic drugs on bone mineral density
Arzu Babayigit et al.
PEDIATRIC NEUROLOGY (2006)
Epilepsy, osteoporosis and fracture risk - a meta-analysis
P Vestergaard
ACTA NEUROLOGICA SCANDINAVICA (2005)
Vitamins for epilepsy
LN Ranganathan et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2005)
Effect of carbamazepine and valproate on bone mineral density
CG Ecevit et al.
PEDIATRIC NEUROLOGY (2004)
Bone mineral metabolism changes in epileptic children receiving valproic acid
N Öner et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2004)
Fracture risk associated with use of antiepileptic drugs
P Vestergaard et al.
EPILEPSIA (2004)
Bone mineral status in ambulatory pediatric patients on long-term anti-epileptic drug therapy
H Tsukahara et al.
PEDIATRICS INTERNATIONAL (2002)
Effect of antiepileptic drugs on bone density in ambulatory patients
G Farhat et al.
NEUROLOGY (2002)
Analysis of the musculoskeletal system in children and adolescents receiving anticonvulsant monotherapy with valproic acid or carbamazepine
G Rieger-Wettengl et al.
PEDIATRICS (2001)
Long-term valproate and lamotrigine treatment may be a marker for reduced growth and bone mass in children with epilepsy
CY Guo et al.
EPILEPSIA (2001)
Phenytoin and its metabolite, 5-(4-hydroxyphenyl)-5-phenylhydantoin, show bone resorption in cultured neonatal mouse calvaria
A Takahashi et al.
JAPANESE JOURNAL OF PHARMACOLOGY (2000)
Share Paper
